2026 NPPES data Hematology & Oncology Physician NPI 1083097091 M.D.
Verify on CMS →

Sylvia Alarcon Velasco, M.D.

Hematology & Oncology Physician in Wakefield, Rhode Island.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
127
Medicare Part D claims · 51 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
75%
generic claims · 25% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Sylvia Alarcon Velasco, M.D. filed 127 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Wakefield, Rhode Island, prescribing 75% generic.

127
Part D claims, 2023
75%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Sylvia Alarcon Velasco, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

127 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Sylvia Alarcon Velasco, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Sylvia Alarcon Velasco, M.D.?

Quality data not reported

NPI registry status

Active

Issued 07/08/2015

NPI 1083097091

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

127 85% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Rhode Island

How Hematology & Oncology Physician compares to other specialties among Rhode Island providers

Rhode Island providers
Clinical Social Worker - 8.9%Clinical Social Worker8.9%Mental Health Counselor - 5.3%Mental Health Counselor5.3%Physical Therapist - 4.8%Physical Therapist4.8%Internal Medicine Physician - 4.4%Internal Medicine Physician4.4%Student in an Organized Health Care Education/Training Program - 4.1%Student in an Organized Health Care Education/Training Program4.1%Pharmacist - 4.1%Pharmacist4.1%Hematology & Oncology Physician - 0.2%Hematology & Oncology Physician0.2%
Largest specialties in Rhode Island (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Sylvia Alarcon Velasco, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 100 KENYON AVE, Wakefield, RI, 02879, with a listed phone of (401) 783-6670. NPI 1083097091 was issued on 07/08/2015.

Medicare Part D records for calendar year 2023 show 127 prescription claims written by this provider, covering 51 Medicare beneficiaries and totaling roughly $311K in drug spend, split 25% brand-name and 75% generic by claim count.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

100 KENYON AVE
Wakefield, RI 02879

Provider Details

NPI 1083097091
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 07/08/2015

Brand vs generic prescribing mix · Above average

Sylvia Alarcon Velasco, M.D. - brand share 25.0%
Hematology & Oncology Physician average

25% brand-name claims vs 75% generic, on 127 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

127
Total Claims
$311K
Total Drug Cost
51
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
139
Total Day Supply
3,373
Brand vs Generic
25% brand / 75% generic
Brand Drug Cost
$290K
Generic Drug Cost
$22K

Patient Demographics

Average Patient Age
70.1 years
Avg HCC Risk Score
2.47
Gender Split
39% female / 61% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Sylvia Alarcon Velasco, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ondansetron Hcl
16
Eliquis
Apixaban
13
Ondansetron Odt
Ondansetron
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Sylvia Alarcon Velasco, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Sylvia Alarcon Velasco, M.D.'s 127 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Rhode Island

Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Alarcon Velasco.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Rhode Island medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Sylvia Alarcon Velasco, M.D.'s specialty?
Sylvia Alarcon Velasco, M.D. specializes in Hematology & Oncology Physician and practices in Wakefield, Rhode Island. Credentials: M.D..
How much does Sylvia Alarcon Velasco, M.D. prescribe under Medicare Part D?
In 2023, Sylvia Alarcon Velasco, M.D. wrote 127 Medicare Part D claims totaling $311K in drug costs for 51 beneficiaries.
Where is Sylvia Alarcon Velasco, M.D. located?
Sylvia Alarcon Velasco, M.D. is located at 100 KENYON AVE, Wakefield, RI, 02879. Phone: (401) 783-6670.
What is Sylvia Alarcon Velasco, M.D.'s NPI number?
Sylvia Alarcon Velasco, M.D.'s National Provider Identifier (NPI) is 1083097091, issued on 07/08/2015.
Does Sylvia Alarcon Velasco, M.D. prescribe more brand-name or generic drugs?
Sylvia Alarcon Velasco, M.D.'s prescribing is 25% brand-name and 75% generic drugs by claim count, with $290K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Sylvia Alarcon Velasco, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Sylvia Alarcon Velasco, M.D.'s most frequently prescribed drugs include Ondansetron Hcl, Eliquis, Ondansetron Odt. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sylvia Alarcon Velasco, M.D. accept Medicare?
Sylvia Alarcon Velasco, M.D. appears in CMS Medicare data with 127 Part D claims and 51 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sylvia Alarcon Velasco, M.D.'s credentials?
Sylvia Alarcon Velasco, M.D.'s NPI is 1083097091 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.